FIGHT SKYROCKETING PRESCRIPTION DRUG COSTS
In today’s world, prescription drug costs are the top driver of increasing health benefit plan costs. As more plan members struggle to afford medications, controlling the cost of prescription drugs and specialty drugs has become a top priority for employers.
Only 1% to 2% of the American public uses specialty drugs, yet they account for approximately 38% of total drug expenditures.
When health plans allow hospitals or pharmacy benefit management (PBM) companies to review authorizations for specialty drugs being dispensed by their own pharmacy, no independent review process is involved. The same is true when medical providers submit specialty drug prescriptions as claims under the medical plan rather than the prescription drug benefit plan.
To help self-funded employer groups avoid these potential conflicts, Diversified’s Pharmasense program provides prior authorization, or pre-certification, of all specialty drug prescriptions. By considering several factors, such as the patient’s condition and clinical evidence related to the drug, the Pharmasense program can deliver tremendous cost savings and quality outcomes for the patient.
Diversified Group works closely with clients to provide quality, affordable healthcare plans. We have the experience you can trust to explore all potential cost control measures, including Pharmasense.
Become Part Of The Solution!
These 5 steps can help achieve lower costs for your plan and better outcomes for your people…
Pharmasense Success Stories
Specialty drugs represent a large and growing percentage of total drug spending. Pharmasense is Diversified’s solution to help you fight these escalating costs.
Inside this free white paper, you’ll find:
Simply fill out the form below to learn more about how Pharmasense can benefit your organization!